PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease - Concepedia

Concepedia

Publication | Open Access

PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease

DOI Full Paper Access

18

Citations

27

References

2020

Year

Seong-Jin Yu, Shuchun Chen, Yung-Yung Yang, Elliot J. Glotfelty, Jin Ho Jung, Hee-Kyung Kim, Ho-Il Choi, Doo‐Sup Choi, Barry J. Hoffer, Nigel H. Greig,

Frontiers in Neuroscience

Abstract

PT320 attenuates L-DOPA/benserazide-induced dyskinesia in a 6-OHDA rat model of PD and warrants clinical evaluation to mitigate Parkinson's disease in humans.

References

	Year	Citations

Page 1